Captodiame
Captodiame
Captodiame (pronounced: cap-toe-dye-ame), also known as Vegesan, is a sedative and anxiolytic drug in the benzodiazepine class. It is used primarily in the treatment of anxiety and insomnia.
Etymology
The term "Captodiame" is derived from the chemical structure of the drug, which is a derivative of the parent compound benzodiazepine. The prefix "capto-" is derived from the Latin word "captus", meaning "to capture", and "diame" is a contraction of "diazepam", a common benzodiazepine drug.
Usage
Captodiame is used primarily for its sedative and anxiolytic effects. It is often prescribed for the treatment of anxiety disorders, including generalized anxiety disorder (GAD) and panic disorder. It is also used in the treatment of insomnia, particularly when anxiety is a contributing factor.
Pharmacology
Captodiame works by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain. GABA is an inhibitory neurotransmitter, meaning it reduces the activity of the neurons to which it binds. By enhancing the effect of GABA, captodiame helps to calm the brain and reduce feelings of anxiety.
Side Effects
Like all benzodiazepines, captodiame can cause a range of side effects. These may include drowsiness, dizziness, confusion, and impaired coordination. Long-term use can lead to dependence and withdrawal symptoms if the drug is discontinued abruptly.
Related Terms
- Benzodiazepine
- Anxiety
- Insomnia
- Sedative
- Anxiolytic
- Gamma-aminobutyric acid
- Generalized anxiety disorder
- Panic disorder
External links
- Medical encyclopedia article on Captodiame
- Wikipedia's article - Captodiame
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski